miRNAs as prognostic and therapeutic tools in epithelial ovarian cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
miRNAs as prognostic and therapeutic tools in epithelial ovarian cancer
Authors
Keywords
-
Journal
Biomarkers in Medicine
Volume 9, Issue 3, Pages 241-257
Publisher
Future Medicine Ltd
Online
2015-03-03
DOI
10.2217/bmm.14.108
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of a chrXq27.3 microRNA cluster associated with early relapse in advanced stage ovarian cancer patients
- (2015) Marina Bagnoli et al. Oncotarget
- Epigenetic silencing of microRNA-199b-5p is associated with acquired chemoresistance via activation of JAG1-Notch1 signaling in ovarian cancer
- (2015) Michelle X. Liu et al. Oncotarget
- The Epidermal Growth Factor Receptor Responsive miR-125a Represses Mesenchymal Morphology in Ovarian Cancer Cells
- (2015) Karen D. Cowden Dahl et al. NEOPLASIA
- MiR-489 modulates cisplatin resistance in human ovarian cancer cells by targeting Akt3
- (2014) Huijuan Wu et al. ANTI-CANCER DRUGS
- Integrative analyses of genetic variation, epigenetic regulation, and the transcriptome to elucidate the biology of platinum sensitivity
- (2014) Bonnie LaCroix et al. BMC GENOMICS
- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Ectopic over-expression of miR-429 induces mesenchymal-to-epithelial transition (MET) and increased drug sensitivity in metastasizing ovarian cancer cells
- (2014) Lijuan Wang et al. GYNECOLOGIC ONCOLOGY
- The inhibition of miR-21 promotes apoptosis and chemosensitivity in ovarian cancer
- (2014) John K. Chan et al. GYNECOLOGIC ONCOLOGY
- MicroRNAs as prognostic markers in ovarian cancer
- (2014) Marta Llauradó et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress
- (2014) Mildred Felder et al. Molecular Cancer
- miR200c Attenuates P-gp-Mediated MDR and Metastasis by Targeting JNK2/c-Jun Signaling Pathway in Colorectal Cancer
- (2014) H. Sui et al. MOLECULAR CANCER THERAPEUTICS
- Clinical relevance of circulating cell-free microRNAs in cancer
- (2014) Heidi Schwarzenbach et al. Nature Reviews Clinical Oncology
- Therapeutic targeting of microRNAs: current status and future challenges
- (2014) Zhonghan Li et al. NATURE REVIEWS DRUG DISCOVERY
- Molecular mechanisms of epithelial–mesenchymal transition
- (2014) Samy Lamouille et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- In-Depth Analysis Shows Synergy between Erlotinib and miR-34a
- (2014) Jane Zhao et al. PLoS One
- Quantitative and stoichiometric analysis of the microRNA content of exosomes
- (2014) J. R. Chevillet et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MicroRNA-449a reduces cell survival and enhances cisplatin-induced cytotoxicity via downregulation of NOTCH1 in ovarian cancer cells
- (2014) Yanqi Zhou et al. TUMOR BIOLOGY
- MiR-519d represses ovarian cancer cell proliferation and enhances cisplatin-mediated cytotoxicity in vitro by targeting XIAP
- (2014) Yingxin Pang et al. OncoTargets and Therapy
- microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial–mesenchymal transition
- (2014) Aditya Parikh et al. Nature Communications
- Regulation of Metastasis by microRNAs in Ovarian Cancer
- (2014) Yongchao Wang et al. Frontiers in Oncology
- Downregulation of miR-130a contributes to cisplatin resistance in ovarian cancer cells by targeting X-linked inhibitor of apoptosis (XIAP) directly
- (2013) X. Zhang et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Berberine sensitizes ovarian cancer cells to cisplatin through miR-21/PDCD4 axis
- (2013) S. Liu et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Identification of Serum MicroRNA-21 as a Biomarker for Early Detection and Prognosis in Human Epithelial Ovarian Cancer
- (2013) Yun-Zhao Xu et al. Asian Pacific Journal of Cancer Prevention
- Chemoresistance in ovarian cancer linked to expression of microRNAs
- (2013) PJ Frederick et al. BIOTECHNIC & HISTOCHEMISTRY
- Pharmaco-miR: linking microRNAs and drug effects
- (2013) J. L. Rukov et al. BRIEFINGS IN BIOINFORMATICS
- Transformation of the Fallopian Tube Secretory Epithelium Leads to High-Grade Serous Ovarian Cancer in Brca;Tp53;Pten Models
- (2013) Ruth Perets et al. CANCER CELL
- Integrated Analyses Identify a Master MicroRNA Regulatory Network for the Mesenchymal Subtype in Serous Ovarian Cancer
- (2013) Da Yang et al. CANCER CELL
- Towards a personalized breast cancer treatment approach guided by circulating tumor cell (CTC) characteristics
- (2013) W. Onstenk et al. CANCER TREATMENT REVIEWS
- MicroRNAs as therapeutic targets in chemoresistance
- (2013) Michela Garofalo et al. DRUG RESISTANCE UPDATES
- The IGF2 intronic miR-483 selectively enhances transcription from IGF2 fetal promoters and enhances tumorigenesis
- (2013) M. Liu et al. GENES & DEVELOPMENT
- Predictive value of circulating tumor cells (CTCs) in newly-diagnosed and recurrent ovarian cancer patients
- (2013) Joyce F. Liu et al. GYNECOLOGIC ONCOLOGY
- Downregulation ofmiR-29contributes to cisplatin resistance of ovarian cancer cells
- (2013) Pei-Ning Yu et al. INTERNATIONAL JOURNAL OF CANCER
- MicroRNA-138 suppresses ovarian cancer cell invasion and metastasis by targeting SOX4 and HIF-1α
- (2013) Yu-Ming Yeh et al. INTERNATIONAL JOURNAL OF CANCER
- MiR-106a targets Mcl-1 to suppress cisplatin resistance of ovarian cancer A2780 cells
- (2013) Yu-mei Rao et al. Journal of Huazhong University of Science and Technology-Medical Sciences
- Serum microRNA-92 expression in patients with ovarian epithelial carcinoma
- (2013) Fengjun Guo et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Prognostic significance of serum microRNA-221 expression in human epithelial ovarian cancer
- (2013) Fanzhen Hong et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profiling
- (2013) Ali Bashashati et al. JOURNAL OF PATHOLOGY
- miR-9 Regulation of BRCA1 and Ovarian Cancer Sensitivity to Cisplatin and PARP Inhibition
- (2013) Chaoyang Sun et al. JNCI-Journal of the National Cancer Institute
- Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden
- (2013) Khalid Abubaker et al. Molecular Cancer
- Systematic Screen Identifies miRNAs That Target RAD51 and RAD51D to Enhance Chemosensitivity
- (2013) J.-W. Huang et al. MOLECULAR CANCER RESEARCH
- Urokinase Plasminogen Activator System-Targeted Delivery of Nanobins as a Novel Ovarian Cancer Therapy
- (2013) Y. Zhang et al. MOLECULAR CANCER THERAPEUTICS
- Tumour heterogeneity in the clinic
- (2013) Philippe L. Bedard et al. NATURE
- Influence of tumour micro-environment heterogeneity on therapeutic response
- (2013) Melissa R. Junttila et al. NATURE
- Control of metastatic progression by microRNA regulatory networks
- (2013) Nora Pencheva et al. NATURE CELL BIOLOGY
- MicroRNAs and other non-coding RNAs as targets for anticancer drug development
- (2013) Hui Ling et al. NATURE REVIEWS DRUG DISCOVERY
- MicroRNAs and cancer stem cells: the sword and the shield
- (2013) X Sun et al. ONCOGENE
- MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine
- (2013) Y Xiang et al. ONCOGENE
- Increased Sensitivity to Chemotherapy Induced by CpG-ODN Treatment Is Mediated by microRNA Modulation
- (2013) Loris De Cecco et al. PLoS One
- Assessing an Improved Protocol for Plasma microRNA Extraction
- (2013) Inés Moret et al. PLoS One
- Plasma miRNAs as Diagnostic and Prognostic Biomarkers for Ovarian Cancer
- (2013) Hong Zheng et al. PLoS One
- A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis
- (2013) A. Vecchione et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The p53 miRNA interactome and its potential role in the cancer clinic
- (2013) Jonathan Krell et al. Epigenomics
- Therapeutic Synergy between microRNA and siRNA in Ovarian Cancer Treatment
- (2013) M. Nishimura et al. Cancer Discovery
- MicroRNAs overexpressed in ovarian ALDH1-positive cells are associated with chemoresistance
- (2013) Young Tae Park et al. Journal of Ovarian Research
- MicroRNA-200c overexpression inhibits tumorigenicity and metastasis of CD117+CD44+ ovarian cancer stem cells by regulating epithelial-mesenchymal transition
- (2013) Dengyu Chen et al. Journal of Ovarian Research
- Deregulation of let-7e in epithelial ovarian cancer promotes the development of resistance to cisplatin
- (2013) J Cai et al. Oncogenesis
- Genomic analyses to select patients for adjuvant chemotherapy: trials and tribulations
- (2012) B. Weigelt et al. ANNALS OF ONCOLOGY
- Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancer
- (2012) Casina WS Kan et al. BMC CANCER
- MicroRNA control of epithelial–mesenchymal transition and metastasis
- (2012) Jinsong Zhang et al. CANCER AND METASTASIS REVIEWS
- MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells
- (2012) Weiwei Cheng et al. FEBS Journal
- Involvement of microRNA-93, a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells
- (2012) Xin Fu et al. FEBS LETTERS
- MicroRNA MiR-214 Regulates Ovarian Cancer Cell Stemness by Targeting p53/Nanog
- (2012) Cheng-Xiong Xu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- TGF-β upregulates miR-181a expression to promote breast cancer metastasis
- (2012) Molly A. Taylor et al. JOURNAL OF CLINICAL INVESTIGATION
- Involvement of miRNAs in ovarian follicular and luteal development
- (2012) F X Donadeu et al. JOURNAL OF ENDOCRINOLOGY
- Intratumoral Heterogeneity of MicroRNA Expression in Breast Cancer
- (2012) Mithu Raychaudhuri et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- MiR-182 overexpression in tumourigenesis of high-grade serous ovarian carcinoma
- (2012) Zhaojian Liu et al. JOURNAL OF PATHOLOGY
- Revisiting the Complexity of the Ovarian Cancer Microenvironment--Clinical Implications for Treatment Strategies
- (2012) N. Musrap et al. MOLECULAR CANCER RESEARCH
- Genetic Variation That Predicts Platinum Sensitivity Reveals the Role of miR-193b* in Chemotherapeutic Susceptibility
- (2012) D. Ziliak et al. MOLECULAR CANCER THERAPEUTICS
- MicroRNA profiling: approaches and considerations
- (2012) Colin C. Pritchard et al. NATURE REVIEWS GENETICS
- miR-34a functions as a tumor suppressor modulating EGFR in glioblastoma multiforme
- (2012) D Yin et al. ONCOGENE
- miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells
- (2012) M T M van Jaarsveld et al. ONCOGENE
- MicroRNAs Reprogram Normal Fibroblasts into Cancer-Associated Fibroblasts in Ovarian Cancer
- (2012) A. K. Mitra et al. Cancer Discovery
- Aldehyde Dehydrogenase in Combination with CD133 Defines Angiogenic Ovarian Cancer Stem Cells That Portend Poor Patient Survival
- (2011) I. A. Silva et al. CANCER RESEARCH
- Stem Cell Pathways Contribute to Clinical Chemoresistance in Ovarian Cancer
- (2011) A. D. Steg et al. CLINICAL CANCER RESEARCH
- Epigenetic silencing of miR-130b in ovarian cancer promotes the development of multidrug resistance by targeting colony-stimulating factor 1
- (2011) Chun Yang et al. GYNECOLOGIC ONCOLOGY
- Bim Protein Degradation Contributes to Cisplatin Resistance
- (2011) Juan Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MicroRNA 376c enhances ovarian cancer cell survival by targeting activin receptor-like kinase 7: implications for chemoresistance
- (2011) G. Ye et al. JOURNAL OF CELL SCIENCE
- Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profile
- (2011) Ardian Latifi et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- miR-125b confers resistance of ovarian cancer cells to cisplatin by targeting pro-apoptotic Bcl-2 antagonist killer 1
- (2011) Fanfei Kong et al. Journal of Huazhong University of Science and Technology-Medical Sciences
- Evolution of platinum resistance in high-grade serous ovarian cancer
- (2011) Susanna L Cooke et al. LANCET ONCOLOGY
- MicroRNA-30c-2* Expressed in Ovarian Cancer Cells Suppresses Growth Factor-Induced Cellular Proliferation and Downregulates the Oncogene BCL9
- (2011) W. Jia et al. MOLECULAR CANCER RESEARCH
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- Ovarian Cancer Development and Metastasis
- (2010) Ernst Lengyel AMERICAN JOURNAL OF PATHOLOGY
- Molecular Profiling Uncovers a p53-Associated Role for MicroRNA-31 in Inhibiting the Proliferation of Serous Ovarian Carcinomas and Other Cancers
- (2010) C. J. Creighton et al. CANCER RESEARCH
- Frequent Downregulation of miR-34 Family in Human Ovarian Cancers
- (2010) D. C. Corney et al. CLINICAL CANCER RESEARCH
- Deregulation of miR-519a, 153, and 485-5p and its clinicopathological relevance in ovarian epithelial tumours
- (2010) Tae Heon Kim et al. HISTOPATHOLOGY
- MicroRNAs in ovarian cancer biology and therapy resistance
- (2010) Marijn T.M. van Jaarsveld et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- MicroRNA profiling: separating signal from noise
- (2010) Monya Baker NATURE METHODS
- Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma
- (2010) S L Cooke et al. ONCOGENE
- Distinct Expression Levels and Patterns of Stem Cell Marker, Aldehyde Dehydrogenase Isoform 1 (ALDH1), in Human Epithelial Cancers
- (2010) Shan Deng et al. PLoS One
- The miR-34 family in cancer and apoptosis
- (2009) H Hermeking CELL DEATH AND DIFFERENTIATION
- A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer
- (2009) Xiaoxia Hu et al. GYNECOLOGIC ONCOLOGY
- Tumor microRNA expression patterns associated with resistance to platinum based chemotherapy and survival in ovarian cancer patients
- (2009) Ram Eitan et al. GYNECOLOGIC ONCOLOGY
- Role of microRNAs in ovarian cancer pathogenesis and potential clinical implications
- (2009) Delia Mezzanzanica et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- The Future of Targeted Therapies in Ovarian Cancer
- (2009) S. Banerjee et al. ONCOLOGIST
- MicroRNA Profiling of BRCA1/2 Mutation-Carrying and Non-Mutation-Carrying High-Grade Serous Carcinomas of Ovary
- (2009) Cheng-Han Lee et al. PLoS One
- Role of CA125 in predicting ovarian cancer survival - a review of the epidemiological literature
- (2009) Digant Gupta et al. Journal of Ovarian Research
- Targeting the Epidermal Growth Factor Receptor in Epithelial Ovarian Cancer: Current Knowledge and Future Challenges
- (2009) Doris R. Siwak et al. Journal of Oncology
- MicroRNA Microarray Identifies Let-7i as a Novel Biomarker and Therapeutic Target in Human Epithelial Ovarian Cancer
- (2008) N. Yang et al. CANCER RESEARCH
- MicroRNA Expression Profiling in Human Ovarian Cancer: miR-214 Induces Cell Survival and Cisplatin Resistance by Targeting PTEN
- (2008) H. Yang et al. CANCER RESEARCH
- MicroRNA Expression Profiles in Serous Ovarian Carcinoma
- (2008) E. J. Nam et al. CLINICAL CANCER RESEARCH
- The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
- (2008) S.-M. Park et al. GENES & DEVELOPMENT
- Role of microRNAs in drug-resistant ovarian cancer cells
- (2008) Antonio Sorrentino et al. GYNECOLOGIC ONCOLOGY
- MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer
- (2008) Douglas D. Taylor et al. GYNECOLOGIC ONCOLOGY
- The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform
- (2008) Kimberly E. Resnick et al. GYNECOLOGIC ONCOLOGY
- Regulation of IKKβ by miR-199a affects NF-κB activity in ovarian cancer cells
- (2008) R Chen et al. ONCOGENE
- Circulating microRNAs as stable blood-based markers for cancer detection
- (2008) P. S. Mitchell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started